James Hardie Industries Slides as Investors Reassess Near-Term Catalysts

James Hardie Industries plc (JHX) is down 6.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The catalyst appears somewhat unclear, because there has not been an obvious new negative filing tied directly to today’s drop. This could be because investors are taking profits after a recent run to a 52-week high and reassessing whether the company’s September 15 investor-day event will add enough near-term upside beyond the guidance increase and portfolio changes already announced.

Details:

On August 6, the company reported first-quarter FY27 results ahead of its original guidance and raised its full-year outlook, which means a stronger near-term earnings story was already in the share price.

On August 20, James Hardie agreed to sell its European fibre gypsum and cement-bonded products business for €840 million, a move meant to sharpen the portfolio and focus capital on higher-priority growth areas.

The company had flagged September 15 as its 2026 Investor Day, so a selloff around that date can happen when traders were positioned for a fresh catalyst and the market does not immediately see a new earnings step-up.

JHX recently touched a 52-week high on September 8, which supports the idea that some of today’s weakness may be simple profit-taking after a strong recent move.

Sources:

James Hardie Investor Relations, SEC, Yahoo Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$JHX Insider Trading Activity

$JHX insiders have traded $JHX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $JHX stock by insiders over the last 6 months:

JESSE G SINGH has made 0 purchases and 5 sales selling 871,557 shares for an estimated $26,330,520.
JONATHAN SKELLY (Pres. James Hardie NA) has made 0 purchases and 2 sales selling 65,000 shares for an estimated $1,979,750.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$JHX Hedge Fund Activity

We have seen 181 institutional investors add shares of $JHX stock to their portfolio, and 182 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP removed 11,962,062 shares (-22.7%) from their portfolio in Q2 2026, for an estimated $313,166,783
INVESCO LTD. added 11,913,790 shares (+inf%) to their portfolio in Q2 2026, for an estimated $311,903,022
MILLENNIUM MANAGEMENT LLC added 10,715,912 shares (+317.8%) to their portfolio in Q2 2026, for an estimated $280,542,576
FMR LLC added 6,535,799 shares (+20.9%) to their portfolio in Q2 2026, for an estimated $171,107,217
JPMORGAN CHASE & CO added 6,205,799 shares (+inf%) to their portfolio in Q2 2026, for an estimated $162,467,817
PHOENIX FINANCIAL LTD. removed 5,449,639 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $142,671,549
PALESTRA CAPITAL MANAGEMENT LLC added 4,130,497 shares (+inf%) to their portfolio in Q2 2026, for an estimated $108,136,411

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$JHX Price Targets

Multiple analysts have issued price targets for $JHX recently. We have seen 2 analysts offer price targets for $JHX in the last 6 months, with a median target of $26.0.

Here are some recent targets:

James Hardie from Stephens & Co. set a target price of $31.0 on 06/26/2026
Matthew Bouley from Barclays set a target price of $21.0 on 05/21/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.